IMMETAS
Immetas is a developer of novel therapeutic solutions for treating cancers and inflammatory diseases.
IMMETAS
Industry:
Bioinformatics Biotechnology Health Care
Address:
East Hanover, New Jersey, United States
Country:
United States
Website Url:
http://www.immetas.com
Status:
Active
Current Employees Featured
Founder
Official Site Inspections
http://www.immetas.com Semrush global rank: 5.18 M Semrush visits lastest month: 1.56 K
- Host name: box5328.bluehost.com
- IP address: 162.241.230.122
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Immetas"
Immetas
Immetas discovers and develops novel therapeutics that modulate the innate immune system to treat age-related cancers and inflammatory diseases. The company’s approach is based on emerging evidence that chronic low-grade …See details»
Immetas - Crunchbase Company Profile & Funding
Organization. Immetas . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Immetas is located in East Hanover, New Jersey, United States. …See details»
Team - Immetas
He completed his medical residency training at Yale New Haven Hospital. Dr. Wang launched Immetas with Dr. Sinclair in October, 2018. ... Prior to joining Morningside, Dr. Huang was with …See details»
Immetas Company Profile 2024: Valuation, Funding & Investors
Immetas General Information Description. Developer of novel therapeutics designed to modulate the innate immune system to treat age-related cancer and inflammatory diseases. The …See details»
Immetas Therapeutics - VentureRadar
Immetas discovers and develops novel therapeutics that modulate the innate immune system to treat age-related cancers and inflammatory diseases. The company’s approach is based on …See details»
Immetas Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jan 16, 2024 Explore Immetas Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Approach - Immetas
Immetas’ strategy begins with clinical data, including from human genetic disorders and clinical trials involving the relevant targets; by matching molecular profiling of the target pathways with disease signatures; and by applying …See details»
Immetas - Company Profile - Tracxn
Jun 25, 2024 Competitive landscape of Immetas Immetas has a total of 2910 competitors and it ranks 630 th among them. 913 of its competitors are funded while 547 have exited. Overall, …See details»
Immetas Therapeutics - Overview, News & Similar companies
Oct 11, 2023 Immetas was founded by J. Gene Wang, MD, PhD, a veteran in discovery and translational drug development in immunology/ inflammation and oncology, and David Sinclair, …See details»
Immetas - Company Profile - Tracxn
Immetas - Developer of therapeutic solutions for treating cancers and inflammatory diseases. Raised a total funding of $11M over 1 round from 1 investor. Founded by J Gene Wang and …See details»
Immetas Therapeutics DMF, CEP, Written Confirmations, FDF, …
Immetas discovers and develops novel therapeutics that modulate the innate immune system to treat age-related cancers and inflammatory diseases. The company’s approach is based on …See details»
Immetas - Crunchbase
Immetas is a developer of novel therapeutic solutions for treating cancers and inflammatory diseases.See details»
Immetas - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Immetas . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Immetas has 2 current …See details»
Immetas Therapeutics Announces Series A Financing to Advance …
Sep 22, 2020 Immetas discovers and develops novel therapeutics that modulate the innate immune system to treat age-related cancers and inflammatory diseases. The company’s …See details»
Immetas - Raised $11M Funding from 1 investor - Tracxn
Nov 5, 2024 Immetas raised $11M in its latest funding round, which was Series A round held on Sep 23, 2020. How much funding has Immetas raised till date? Immetas has raised a total …See details»
GC and Immetas Therapeutics to co-develop autoimmune disease …
Oct 13, 2023 Meanwhile, Immetas, a biotech venture based in New Jersey, U.S., develops treatments for aging-related cancer and inflammatory diseases by regulating the innate …See details»
Immetas Therapeutics and GC Biopharma Announce Research …
May 1, 2024 East Hanover, NJ and Yongin, South Korea -October 12, 2023 – Immetas Therapeutics and GC Biopharma today announced that they have entered into a research …See details»
News & Contact - Immetas
May 1, 2024 East Hanover, NJ and Yongin, South Korea -October 12, 2023 – Immetas Therapeutics and GC Biopharma today announced that they have entered into a research …See details»
Immetas - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Immetas . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. Monthly Visits 1. Monthly Visits …See details»
Science - Immetas
Therapeutics targeting immune system have generated abundant clinical data, which Immetas is leveraging to develop drugs that modulate innate and adaptive immune responses. Targeting …See details»